Influence of oncolytic strains of a new unclassified group of human rotaviruses on peripheral blood lymphocytes

Purpose of the study. Evaluation of the cytotoxic effect of strains RVK100 and RVK228 of a new unclassified group of human rotaviruses on human peripheral blood mononuclear cells in vitro.
Materials and methods. As a material for the study, we used peripheral blood mononuclear cells of a healthy donor. The cells were exposed to two strains of rotaviruses RVK100 and RVK228 for 24 and 48 hours. The cytotoxicity of the tested viruses was assessed using the Colorimetric Cell Viability Kit I (WST-8) (PromoCell, Germany). Analysis of lymphocytes subpopulation composition was assessed on a FACSCantoII flow cytometer (BD, USA) using monoclonal antibodies to human antigens: CD3, CD4, CD8, CD16/56, CD19, CD45, CD38, HLA-DR.
Results. According to the cell viability test, there was no significant decrease in the number of living cells in the samples with the addition of viruses in comparison with the control. On the contrary, after 48 hours of cultivation in the samples with the addition of RVK228, the number of living cells was significantly higher than in the control. The study of lymphocytes subpopulation composition showed a relative increase in the number of early activation markers on T cells in samples with viruses, which was also more pronounced in samples with the addition of RVK228.
Conclusion. The investigated strains of rotaviruses have no cytotoxic effect on human peripheral blood mononuclear cells. Moreover, the RVK228 strain is likely to have the ability to activate lymphocytes.

1. Naghavi M., Abajobir A.A., Abbafati C., Abbas K.M., Abd-Allah F., Abera S.F, Aboyans V., et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-1210. https://doi.org/10.1016/S0140-6736(17)32152-9.

2. Liang M. Oncorine, the world first oncolytic virus medicine and its update in China. Curr. Cancer Drug Targets. 2018;18(2):171-176. https://doi.org/10.2174/1568009618666171129221503.

3. Conry R.M., Westbrook B., McKee S., Norwood T.G. Talimogene laherparepvec: first in class oncolytic virotherapy. Hum. Vaccin. Immunother. 2018;14(4):839-846. https://doi.org/10.1080/21645515.2017.1412896.

4. Mesev E.V., LeDesma R.A., Ploss A. Decoding type I and III interferon signalling during viral infection. Nat Microbiol. 2019;4(6):914-924. https://doi.org/10.1038/s41564-019-0421-x.

5. Dyer A., Schoeps B., Frost S., Jakeman P., Scott E.M., Freedman J., Jacobus E.J., Seymour L.W. Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells. Cancer Res. 2019;79(2):331-345. https://doi.org/10.1158/0008-5472.CAN-18-1326.

6. Russell S.J., Peng K.W., Bell J.C. Oncolytic virotherapy. Nat Biotechnol. 2012;30(7):658-70. https://doi.org/10.1038/nbt.2287.

7. Kolpakov S.A., Kolpakova E.P. A new group of human rotaviruses of the Reoviridae family. Living and bioinert systems. 2014; 10: 6. (In Russian).

8. Kolpakov S.A., Kolpakova E.P., Zlatnik E.Yu. 2019. The strain of a new group of rotaviruses of the Reoviridae family interferes with transplantation and tumor growth of rat ovary in the experiment. Malignant tumors. V. 9. № 3. P. 135. (In Russian).

9. Zlatnik E.Yu., Kolpakov S.A., Kolpakova E.P., Sitkovskaya A.O., Shulgina O.G., Nepomnyashchaya E.M. Investigation of the oncolytic effect of a new unclassified group of human rotaviruses of the family Reoviridae on epidermoid carcinoma in vivo. White Nights 2020: Abstracts of the VI St. Petersburg International Oncological Forum, St. Petersburg, June 25-28, 2020. - St. Petersburg: Problems of Oncology, 2020: 138. (In Russian).

10. Sitkovskaya A.O., Filippova S.Yu., Zlatnik E.Yu., Kolpakov S.A., Kolpakova E.P., Mezhevova I.V., Bondarenko E.S., et al. Cytotoxic effect of unclassified rotaviruses of the group K on cultures of T98G and U87MG cells in vitro. Cytology. 2020; 62 (3): 189-200. (In Russian). https://doi.org/10.31857/S0041377120030062.

11. Sitkovskaya A.O., Zlatnik E.Yu., Filippova S.Yu., Bondarenko E.S., Vaschenko L.N., Kechedzhieva E.E., Dashkova I.R., et al. Influence of interleukins 2, 7 , 15 on the proliferation of natural killer cells in vitro. Russian biotherapeutic journal. 2021;20(1):56-66. (In Russian). https://doi.org/10.17650/1726-9784-2021-20-1-56-66.

12. Yasukawa M, Nakagomi O, Kobayashi Y. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin Exp Immunol. 1990;80(1):49-55. https://doi.org/10.1111/j.1365-2249.1990.tb06440.x.

13. Mesa M.C., Rodríguez L.S., Franco M.A., Angel J. Interaction of rotavirus with human peripheral blood mononuclear cells: plasmacytoid dendritic cells play a role in stimulating memory rotavirus specific T cells in vitro. Virology. 2007;366(1):174-84. https://doi.org/10.1016/j.virol.2007.04.007.

14. Pane J.A., Webster N.L., Coulson B.S. Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells. PLoS Pathog. 2014;10(3):e1003998. https://doi.org/10.1371/journal.ppat.1003998.